Published in Nat Immunol on November 01, 2006
CD150- side population cells represent a functionally distinct population of long-term hematopoietic stem cells. Blood (2007) 2.27
Stem cell niche dynamics: from homeostasis to carcinogenesis. Stem Cells Int (2012) 0.81
Acute lymphoblastic leukemia and developmental biology: a crucial interrelationship. Cell Cycle (2011) 0.79
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol (2010) 6.55
Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science (2010) 4.22
The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells (2005) 1.97
A CD133-expressing murine liver oval cell population with bilineage potential. Stem Cells (2007) 1.87
Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans. Blood (2012) 1.85
The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res (2005) 1.84
Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging. Blood (2003) 1.79
Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A (2010) 1.74
The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry (2002) 1.68
Perivascular support of human hematopoietic stem/progenitor cells. Blood (2013) 1.67
Expansion of multipotent and lymphoid-committed human progenitors through intracellular dimerization of Mpl. Blood (2008) 1.51
Isolation of a putative progenitor subpopulation of alveolar epithelial type 2 cells. Am J Physiol Lung Cell Mol Physiol (2003) 1.42
Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J Clin Invest (2002) 1.41
Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID). Clin Immunol (2005) 1.40
The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol (2008) 1.36
Distinct homeostatic requirements of CD4+ and CD4- subsets of Valpha24-invariant natural killer T cells in humans. Blood (2004) 1.32
Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation. Hepatology (2007) 1.30
Immune-cell lineage commitment: translation from mice to humans. Immunity (2007) 1.29
Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice. Hepatology (2008) 1.27
Lymphoid priming in human bone marrow begins before expression of CD10 with upregulation of L-selectin. Nat Immunol (2012) 1.22
Inferring relative numbers of human leucocyte genome replications. Br J Haematol (2008) 1.22
Identification of the critical extracellular matrix proteins that promote human embryonic stem cell assembly. Stem Cells Dev (2009) 1.15
Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposon. Exp Hematol (2006) 1.13
Human intrathymic lineage commitment is marked by differential CD7 expression: identification of CD7- lympho-myeloid thymic progenitors. Blood (2007) 1.12
Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy. Blood (2013) 1.08
Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system. Hum Gene Ther (2009) 1.08
Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm (2006) 1.08
Contribution of proliferation and DNA damage repair to alveolar epithelial type 2 cell recovery from hyperoxia. Am J Physiol Lung Cell Mol Physiol (2005) 1.05
Lipid rafts are required for Kit survival and proliferation signals. Blood (2007) 1.03
VEGF-mediated cross-talk within the neonatal murine thymus. Blood (2008) 0.97
Ikaros isoform x is selectively expressed in myeloid differentiation. J Immunol (2003) 0.96
Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells. PLoS One (2012) 0.95
Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report. Blood (2006) 0.95
Bone marrow fails to differentiate into liver epithelium during murine development and regeneration. Hepatology (2007) 0.94
Immune reconstitution: from stem cells to lymphocytes. Biol Blood Marrow Transplant (2006) 0.89
Lysophosphatidic acid mediates myeloid differentiation within the human bone marrow microenvironment. PLoS One (2013) 0.89
The effects of Campath 1H upon graft-versus-host disease, infection, relapse, and immune reconstitution in recipients of pediatric unrelated transplants. Biol Blood Marrow Transplant (2007) 0.88
Critical differences in hematopoiesis and lymphoid development between humans and mice. J Clin Immunol (2012) 0.87
Clinical and genetic heterogeneity in Omenn syndrome and severe combined immune deficiency. Pediatr Transplant (2008) 0.87
SCL expression at critical points in human hematopoietic lineage commitment. Stem Cells (2005) 0.87
Human hematopoietic lineage commitment. Immunol Rev (2002) 0.87
Effects of sublethal irradiation on patterns of engraftment after murine bone marrow transplantation. Biol Blood Marrow Transplant (2010) 0.87
Formation of pancreatic duct epithelium from bone marrow during neonatal development. Stem Cells (2006) 0.86
Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells. Mol Ther (2002) 0.86
Busulfan and cyclophosphamide as a conditioning regimen for pediatric acute lymphoblastic leukemia patients undergoing bone marrow transplantation. J Pediatr Hematol Oncol (2004) 0.85
Successful anti-CD20 monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency. Am J Hematol (2004) 0.84
Engineering the human thymic microenvironment to support thymopoiesis in vivo. Stem Cells (2014) 0.84
Successful hematopoietic stem cell transplantation for Niemann-Pick disease type B. Pediatrics (2005) 0.84
Wiskott-Aldrich syndrome protein is an effector of Kit signaling. Blood (2009) 0.84
Dysregulated gene expression during hematopoietic differentiation from human embryonic stem cells. Mol Ther (2010) 0.82
Use of lentiviral vectors to induce long-term tolerance to gal(+) heart grafts. Transplantation (2004) 0.82
Direct interaction between Kit and the interleukin-7 receptor. Blood (2007) 0.82
Fluorescent immunohistochemistry and in situ hybridization analysis of pancreas. Methods Mol Biol (2009) 0.82
The challenges and promises of blood engineered from human pluripotent stem cells. Adv Drug Deliv Rev (2011) 0.81
Fluorescent immunohistochemistry and in situ hybridization analysis of mouse pancreas using low-power antigen-retrieval technique. J Histochem Cytochem (2006) 0.81
Complex chemoattractive and chemorepellent Kit signals revealed by direct imaging of murine mast cells in microfluidic gradient chambers. Integr Biol (Camb) (2013) 0.80
Combined preconditioning and in vivo chemoselection with 6-thioguanine alone achieves highly efficient reconstitution of normal hematopoiesis with HPRT-deficient bone marrow. Exp Hematol (2011) 0.80
Quantum dot labeling and tracking of human leukemic, bone marrow and cord blood cells. Leuk Res (2006) 0.79
Isolation of CD133+ liver stem cells for clonal expansion. J Vis Exp (2011) 0.79
Erythropoiesis from human embryonic stem cells through erythropoietin-independent AKT signaling. Stem Cells (2014) 0.79
Rapid thymic reconstitution following bone marrow transplantation in neonatal mice is VEGF-dependent. Biol Blood Marrow Transplant (2012) 0.78
Anti-CD52 antibody-mediated immune ablation with autologous immune recovery for the treatment of refractory juvenile polymyositis. J Clin Immunol (2011) 0.78
Regulated expansion of human pancreatic beta-cells. Mol Ther (2010) 0.75
Pre- and post-natal treatment of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer (2009) 0.75
Uncertainty plagues US stem cell research. Pediatr Res (2010) 0.75
Invasive Fungal Disease in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant. J Pediatr Hematol Oncol (2016) 0.75
Second hematopoietic stem cell transplantation in pediatric patients: overall survival and long-term follow-up. Biol Blood Marrow Transplant (2002) 0.75